In addition, Zhou and colleagues represented that miR-144 targets the Nrf2-dependent antioxidant system, which hepatocellular carcinoma cell lines use to regain chemoresistance (21). The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.